Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. PLoS One. 2018; 13(11):e0205139.
View in:
PubMed
subject areas
Acquired Immunodeficiency Syndrome
Adenoviridae
Adult
AIDS Vaccines
Antigens, Viral
env Gene Products, Human Immunodeficiency Virus
Female
Genetic Vectors
HIV-1
Humans
Immunity, Cellular
Male
Middle Aged
Virus Replication
Young Adult
authors with profiles
Dan Hung Barouch, M.D.
Joseph Patrick Nkolola, Ph.D.
Kathryn Elaine Stephenson, M.D.